Arteris, Inc. (NASDAQ:AIP) Short Interest Down 21.6% in February

Arteris, Inc. (NASDAQ:AIPGet Free Report) was the recipient of a significant decrease in short interest in February. As of February 15th, there was short interest totalling 302,200 shares, a decrease of 21.6% from the January 31st total of 385,400 shares. Based on an average trading volume of 281,100 shares, the short-interest ratio is currently 1.1 days. Approximately 1.2% of the company’s stock are short sold.

Insider Activity at Arteris

In other news, Director Isabelle F. Geday sold 15,550 shares of the business’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $9.03, for a total value of $140,416.50. Following the completion of the sale, the director now directly owns 121,213 shares in the company, valued at approximately $1,094,553.39. The trade was a 11.37 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Wayne C. Cantwell sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $11.01, for a total value of $55,050.00. Following the sale, the director now directly owns 233,198 shares in the company, valued at approximately $2,567,509.98. This represents a 2.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 360,046 shares of company stock valued at $3,767,475 over the last ninety days. Corporate insiders own 33.70% of the company’s stock.

Institutional Investors Weigh In On Arteris

A number of hedge funds have recently made changes to their positions in the business. PVG Asset Management Corp acquired a new stake in Arteris in the 4th quarter valued at approximately $151,000. PharVision Advisers LLC bought a new position in shares of Arteris in the fourth quarter worth $173,000. Squarepoint Ops LLC acquired a new position in shares of Arteris during the fourth quarter valued at $160,000. Two Sigma Advisers LP raised its stake in shares of Arteris by 82.9% during the fourth quarter. Two Sigma Advisers LP now owns 23,600 shares of the company’s stock valued at $240,000 after purchasing an additional 10,700 shares in the last quarter. Finally, Two Sigma Investments LP lifted its holdings in Arteris by 166.0% in the fourth quarter. Two Sigma Investments LP now owns 60,533 shares of the company’s stock worth $617,000 after purchasing an additional 37,772 shares during the period. Institutional investors own 64.36% of the company’s stock.

Arteris Stock Performance

AIP stock opened at $8.31 on Tuesday. Arteris has a 1 year low of $5.76 and a 1 year high of $12.64. The stock has a market capitalization of $340.28 million, a price-to-earnings ratio of -9.55 and a beta of 1.18. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.17 and a current ratio of 1.17. The stock’s fifty day moving average is $10.46 and its two-hundred day moving average is $8.83.

Arteris (NASDAQ:AIPGet Free Report) last issued its quarterly earnings data on Tuesday, February 18th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.08). The firm had revenue of $15.49 million during the quarter, compared to the consensus estimate of $15.34 million. Arteris had a negative net margin of 58.27% and a negative return on equity of 828.71%. On average, research analysts predict that Arteris will post -0.73 EPS for the current year.

Wall Street Analysts Forecast Growth

AIP has been the topic of a number of research reports. Northland Securities increased their target price on shares of Arteris from $14.00 to $16.00 and gave the stock an “outperform” rating in a report on Wednesday, February 19th. Rosenblatt Securities restated a “buy” rating and issued a $15.00 target price on shares of Arteris in a research note on Tuesday, February 18th.

View Our Latest Stock Analysis on Arteris

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Recommended Stories

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.